Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

The chemical treatment market is being actively used by the firm. Tumor, cardiovascular and cerebrovascular, women and children, and other therapeutic regions will be included for biological pharmaceuticals, chemical drug imitations, new research and development, and other collaboration and layout methods. In the future, Yibai plans to grow its pharmaceutical manufacturer, consolidate its major pharmaceutical industry, and build two new sources of growth for biological and chemical pharmaceuticals based on traditional Chinese medicine.

Chengdu Hengling Technology Co., Ltd., established on 2015-03-27, Business scope includes chemical technology,medical technology,Biotechnology R&D,technology transfer,technical consulting(Does not include health care activities);Sell ​​laboratory equipment,medical instruments(first class only,The second type of project without permission),Chemical Products(Free of Hazardous Chemicals);translation service;Advertising Design,make,acting,release(Does not contain balloon ads);art graphic design;type,copy service;Binding service;print printing(Did not obtain the relevant administrative license(approval),Do not carry out business activities).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Menyuan County Snow Grass Bio-Pharmaceutical Co., Ltd., established on 2015-01-21, The scope of business includes research and development of pharmaceuticals,Health products,cosmetic,Biological product(Excluding production and operation);Real estate Chinese medicinal materials and tree planting,Sales;Agricultural and sideline products,Chemical raw materials(Free of Hazardous Chemicals)Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

Beijing Quantum Hi-Tech Pharmaceutical Technology Co., Ltd., established on 2014-06-09, Business scope includes medical technology promotion services,Technical Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Part of Hansoh Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd. is a company headquartered in Jiangsu, China, that manufactures and distributes pharmaceutical products.

Chengdu Microchip Pharmaceutical Co., Ltd., established on 2014-04-28, Business scope includes licensed projects:pharmaceutical production[Branch operation];Drug Wholesale;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Non-residential real estate leases;property management;car park service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sichuan Guokang Pharmaceutical Co., Ltd., established on 2001-11-23, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Health food production;Health food sales;food production;Grain Processed Food Production;Cosmetic production;beverage production;Food Internet Sales(Selling prepackaged food);food business;food business(sell bulk food);food business(Selling prepackaged food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chinese herbal medicine acquisition;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Medical Research and Experimental Development;Chemical product production(No licensed chemical products);Cosmetics Wholesale;Sales of daily chemical products;internet sales(Except for products that require a license for sale)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sichuan Xuhua Pharmaceutical Co., Ltd., established on 1992-07-28, Business scope includes research,to develop,Production,Sales:Granules,tablet,hard capsule,pill(Contains pre-treatment extraction of Chinese herbal medicines),Chinese herbal medicine,Health food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Beijing Tide Pharmaceutical Co., Ltd is a Sino-foreign joint venture that established in May 1995 and located at the core of Beijing Economic-Technological Development Area (DBA). Tide is the first high-tech pharmaceutical enterprise in China with the capability of developing, manufacturing as well as marketing series of targeted drugs.

Shandong Ruian Pharmaceutical Co., Ltd., established on 2007-04-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Medical Research and Experimental Development;Indoor Sanitation Insecticide Sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of packaging materials and products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Synthetic Materials Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Technology Import and Export;Import and export;Class III medical device business;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Quantum Hi-Tech (Beijing) Research Institute Co., Ltd., established on 2003-04-04, Business scope includes research,develop biomedicine,health technology;Technology transfer of own technology,technical consulting,Technical Services.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Jiangsu Kanion Pharma is a pharmaceuticals company based out of LIANYUNGANG. Jiangsu Kanion Pharma representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd., established on 2002-07-10, The business scope includes freeze-dried powder injection,powder injection(cephalosporins),powder injection(Penicillins),small volume injection(Contains anti-tumor),eye drops,lotion,Sterile API(mezlocillin sodium,cefpirome sulfate);mezlocillin acid,azlocillinic acid,Ceftezole,ticarcillinic acid,Cefpirome Hydroiodide,2-bromine-(2-chlorine)Methyl phenylacetate,4,5,6,7-Tetrahydrothieno[3,2-C]pyridine,Isoquinoline-5-Production and sales of sulfonyl chloride(licensed production and operation,Production and operation must be licensed);Operating the export business of self-produced products and related technologies of the enterprise and its member enterprises(Except for goods that the state restricts the company to operate or prohibits export);Operate the production of the enterprise and its member enterprises,Raw and auxiliary materials required for scientific research;Equipment,Instrumentation,Import business of spare parts and related technologies.(Except for goods that the state restricts the company to operate or prohibits imports).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s contracture and Peyronie’s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.

Chengdu Di'ao Pharmaceutical Group Co. Ltd. is a Chinese private company, also operating in CN. The firm manufactures and distributes pharmaceutical products.

Sichuan Credit Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of products related to central nervous system. Its products include capsules, tablets, freeze-dried powder injections, water injections, anti-tumor solid preparations, and traditional Chinese medicines. The company was founded on April 20, 2000 and is headquartered in Luzhou, China.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

Servier are driven by the belief in the excellence of their profession. Theirs is a research-based organization, fulfilling a basic need and dedicated to the future.